161 related articles for article (PubMed ID: 20158477)
1. Recent progress of Src SH2 and SH3 inhibitors as anticancer agents.
Lu XL; Cao X; Liu XY; Jiao BH
Curr Med Chem; 2010; 17(12):1117-24. PubMed ID: 20158477
[TBL] [Abstract][Full Text] [Related]
2. Recent progress of SRC family kinase inhibitors as anticancer agents.
Cao X; You QD; Li ZY; Wang XJ; Lu XY; Liu XR; Xu D; Liu B
Mini Rev Med Chem; 2008 Sep; 8(10):1053-63. PubMed ID: 18782057
[TBL] [Abstract][Full Text] [Related]
3. Novel patented SRC kinase inhibitor.
Lu XL; Liu XY; Cao X; Jiao BH
Curr Med Chem; 2012; 19(12):1821-9. PubMed ID: 22414081
[TBL] [Abstract][Full Text] [Related]
4. Allosteric Modulation of Src Family Kinases with ATP-Competitive Inhibitors.
Register AC; Chakraborty S; Maly DJ
Methods Mol Biol; 2017; 1636():79-89. PubMed ID: 28730474
[TBL] [Abstract][Full Text] [Related]
5. Roles of the SH2 and SH3 domains in the regulation of neuronal Src kinase functions.
Groveman BR; Xue S; Marin V; Xu J; Ali MK; Bienkiewicz EA; Yu XM
FEBS J; 2011 Feb; 278(4):643-53. PubMed ID: 21199370
[TBL] [Abstract][Full Text] [Related]
6. SH2 and SH3 domains as targets for anti-proliferative agents.
Vidal M; Gigoux V; Garbay C
Crit Rev Oncol Hematol; 2001 Nov; 40(2):175-86. PubMed ID: 11682324
[TBL] [Abstract][Full Text] [Related]
7. A Discovery Strategy for Selective Inhibitors of c-Src in Complex with the Focal Adhesion Kinase SH3/SH2-binding Region.
Moroco JA; Baumgartner MP; Rust HL; Choi HG; Hur W; Gray NS; Camacho CJ; Smithgall TE
Chem Biol Drug Des; 2015 Aug; 86(2):144-55. PubMed ID: 25376742
[TBL] [Abstract][Full Text] [Related]
8. The SH3 and SH2 domains are capable of directing specificity in protein interactions between the non-receptor tyrosine kinases cSrc and cYes.
Summy JM; Guappone AC; Sudol M; Flynn DC
Oncogene; 2000 Jan; 19(1):155-60. PubMed ID: 10644991
[TBL] [Abstract][Full Text] [Related]
9. Src protein-tyrosine kinase structure, mechanism, and small molecule inhibitors.
Roskoski R
Pharmacol Res; 2015 Apr; 94():9-25. PubMed ID: 25662515
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
Wybenga-Groot LE; McGlade CJ
Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
[TBL] [Abstract][Full Text] [Related]
11. SH3-dependent stimulation of Src-family kinase autophosphorylation without tail release from the SH2 domain in vivo.
Lerner EC; Smithgall TE
Nat Struct Biol; 2002 May; 9(5):365-9. PubMed ID: 11976726
[TBL] [Abstract][Full Text] [Related]
12. The regulation of N-methyl-D-aspartate receptors by Src kinase.
Groveman BR; Feng S; Fang XQ; Pflueger M; Lin SX; Bienkiewicz EA; Yu X
FEBS J; 2012 Jan; 279(1):20-8. PubMed ID: 22060915
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of Src-family kinases to activation by SH3 domain displacement.
Moroco JA; Craigo JK; Iacob RE; Wales TE; Engen JR; Smithgall TE
PLoS One; 2014; 9(8):e105629. PubMed ID: 25144189
[TBL] [Abstract][Full Text] [Related]
14. Endogenous and synthetic inhibitors of the Src-family protein tyrosine kinases.
Chong YP; Ia KK; Mulhern TD; Cheng HC
Biochim Biophys Acta; 2005 Dec; 1754(1-2):210-20. PubMed ID: 16198159
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the design and synthesis of SH2 inhibitors of Src, Grb2 and ZAP-70.
Vu CB
Curr Med Chem; 2000 Oct; 7(10):1081-100. PubMed ID: 10911019
[TBL] [Abstract][Full Text] [Related]
16. Differences in binding of PI 3-kinase to the src-homology domains 2 and 3 of p56 lck and p59 fyn tyrosine kinases.
Susa M; Rohner D; Bichsel S
Biochem Biophys Res Commun; 1996 Mar; 220(3):729-34. PubMed ID: 8607833
[TBL] [Abstract][Full Text] [Related]
17. Antagonists of the Src homology 2 (SH2) domains of Grb2, Src, Lck and ZAP-70.
García-Echeverria C
Curr Med Chem; 2001 Nov; 8(13):1589-604. PubMed ID: 11562287
[TBL] [Abstract][Full Text] [Related]
18. Binding, domain orientation, and dynamics of the Lck SH3-SH2 domain pair and comparison with other Src-family kinases.
Hofmann G; Schweimer K; Kiessling A; Hofinger E; Bauer F; Hoffmann S; Rösch P; Campbell ID; Werner JM; Sticht H
Biochemistry; 2005 Oct; 44(39):13043-50. PubMed ID: 16185072
[TBL] [Abstract][Full Text] [Related]
19. Novel Roles of SH2 and SH3 Domains in Lipid Binding.
Sipeki S; Koprivanacz K; Takács T; Kurilla A; László L; Vas V; Buday L
Cells; 2021 May; 10(5):. PubMed ID: 34068055
[TBL] [Abstract][Full Text] [Related]
20. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.
Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O
J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
